He, J., Wang, J., Li, S., Li, T., Chen, K., & Zhang, S. (2020). Hypoxia‐inhibited miR‐338‐3p suppresses breast cancer progression by directly targeting ZEB2. Cancer Sci.

He, Juanjuan, Jing Wang, Songchao Li, Teng Li, Kunlun Chen, und Shaojin Zhang. "Hypoxia‐inhibited MiR‐338‐3p Suppresses Breast Cancer Progression By Directly Targeting ZEB2." Cancer Sci 2020.

He, Juanjuan, et al. "Hypoxia‐inhibited MiR‐338‐3p Suppresses Breast Cancer Progression By Directly Targeting ZEB2." Cancer Sci 2020.